Important Risk and Safety Information for Sodium Pertechnetate Tc99m Injection
Radiation risks associated with the use of sodium pertechnetate Tc99m injection are greater in children than in adults.
Sensitivity was assessed by imaging a small size source of sodium pertechnetate (46 MBq), positioned near the center of the field of view and on the rotation axis, for a period of 10 min.
Even though SPEM development was aimed at imaging brain substructures, we assessed the instrument's imaging capabilities focusing on different organs: thyroid, lungs, heart, and bones, labeled with sodium pertechnetate, [sup.
In the upper panels of Figure 3, we show 4 of the 16 projections obtained while imaging the mouse thyroid gland, labeled with sodium pertechnetate.
INDICATIONS AND USAGE: Sodium Pertechnetate Tc 99m Injection is used IN ADULTS as an agent for: Brain Imaging (including cerebral radionuclide angiography), Thyroid Imaging, Salivary Gland Imaging, Placenta Localization, Blood Pool Imaging (including radionuclide angiography), Urinary Bladder Imaging (direct isotopic cystography) for the detection of vesico-ureteral reflux, Nasolacrimal Drainage System Imaging.
IMPORTANT SAFETY INFORMATION: Allergic reactions including anaphylaxis have been reported infrequently following the administration of Sodium Pertechnetate Tc99m Injection.
Each vial of MDP-25 contains freeze-dried (lyophilized) powder that is reconstituted immediately before use with radioactive sodium pertechnetate